NCT06122012View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China

NARecruitingINTERVENTIONAL

Enrollment

136

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

May 31, 2024

Conditions

Diabetic Peripheral Neuropathic Pain

Interventions

DRUG

HSK16149 20mg BID

HSK16149 20mg BID with L-carnitine hydrochloride tablets 2 tablets TID ；Lipoic acid tablets 2 tablets BID with L-carnitine hydrochloride tablets 2 tablets TID；

Trial Locations (1)

471000

RECRUITING

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang

All Listed Sponsors

lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY